BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10368993)

  • 1. [Comparison of the therapeutic effects and acid suppression of H2-receptor antagonist and proton pump inhibitor in patients with gastric body ulcer--a prospective controlled trial].
    Takeyama Y; Matsui T; Yao T; Motomura A; Arita M; Okada M; Tanaka K; Imamura T; Hatakeyama S
    Nihon Shokakibyo Gakkai Zasshi; 1999 May; 96(5):502-10. PubMed ID: 10368993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.
    Wang K; Lin HJ; Perng CL; Tseng GY; Yu KW; Chang FY; Lee SD
    Hepatogastroenterology; 2004; 51(59):1540-3. PubMed ID: 15362796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic ultrasonographic evaluation of gastric ulcer healing on treatment with proton pump inhibitors versus H2-receptor antagonists.
    Tanaka M; Maruoka A; Chijiiwa Y; Tanaka M; Nawata H
    Scand J Gastroenterol; 1994 Dec; 29(12):1140-4. PubMed ID: 7886404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there any acid peptic disease that is refractory to proton pump inhibitors?
    Bardhan KD
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():13-24, discussion 29-31. PubMed ID: 8490075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of feeding on gastric acid suppression in Helicobacter pylori-positive patients treated with a proton pump inhibitor or an H2-receptor antagonist after bleeding from a gastric ulcer.
    Ozawa T; Yoshikawa N; Tomita T; Akita Y; Mitamura K
    J Gastroenterol; 2003; 38(9):844-8. PubMed ID: 14564629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent progress in the drug therapy for gastrointestinal bleeding].
    Nakajima S; Bamba T
    Nihon Rinsho; 1998 Sep; 56(9):2291-6. PubMed ID: 9780708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial.
    Uedo N; Takeuchi Y; Yamada T; Ishihara R; Ogiyama H; Yamamoto S; Kato M; Tatsumi K; Masuda E; Tamai C; Yamamoto S; Higashino K; Iishi H; Tatsuta M
    Am J Gastroenterol; 2007 Aug; 102(8):1610-6. PubMed ID: 17403076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
    Bardhan KD; Naesdal J; Bianchi Porro G; Petrillo M; Lazzaroni M; Hinchliffe RF; Thompson M; Morris P; Daly MJ; Carroll NJ
    Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of gastric ulcer healing by lansoprazole by measurement of ulcer diameter.
    Aoyama N; Kinoshita Y; Misaki F; Himeno S; Kasuga M; Chiba T
    J Clin Gastroenterol; 1995; 20 Suppl 2():S86-9. PubMed ID: 7594351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can optimal acid suppression prevent rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized comparative study.
    Lin HJ; Lo WC; Perng CL; Wang K; Lee FY
    Hepatogastroenterology; 1997; 44(17):1495-9. PubMed ID: 9356879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The therapeutic effect of proton pump inhibitors on Helicobacter pylori-positive gastric ulcers.
    Sasakii M; Joh T; Yokoyama Y; Seno K; Tsuchida K; Kurokawa T; Itoh M
    J Pharm Pharmacol; 1999 Jul; 51(7):825-30. PubMed ID: 10467958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
    Holtmann G; Layer P; Goebell H
    Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptic ulcer recurrence during maintenance therapy with H2-receptor antagonist following first-line therapy with proton pump inhibitor.
    Kaneko E; Hoshihara Y; Sakaki N; Harasawa S; Ashida K; Asaka M; Asaki S; Nakamura T; Kobayashi K; Kajiyama G; Ogawa N; Yao T; Muto Y; Nakazawa S; Takemoto T
    J Gastroenterol; 2000; 35(11):824-31. PubMed ID: 11085491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
    Sakaguchi M; Ashida K; Umegaki E; Miyoshi H; Katsu K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S27-31. PubMed ID: 7594334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection.
    Tomita T; Kim Y; Yamasaki T; Okugawa T; Kondo T; Toyoshima F; Sakurai J; Tanaka J; Morita T; Oshima T; Fukui H; Hori K; Watari J; Matsumoto T; Miwa H
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1441-6. PubMed ID: 22497427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endoscopic ultrasonographic study of gastric ulcer treated with proton pump inhibitor].
    Yoshino J; Nakazawa S; Nakamura T; Yamao K; Inui K; Yamachika H; Watanabe K; Wakabayashi T
    Nihon Rinsho; 1992 Jan; 50(1):81-5. PubMed ID: 1347334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sofalcone, a gastroprotective drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori: a randomized controlled comparative trial with cimetidine, an H2-receptor antagonist.
    Higuchi K; Watanabe T; Tanigawa T; Tominaga K; Fujiwara Y; Arakawa T
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S155-60. PubMed ID: 20586860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing acid suppression for treatment of acid-related diseases.
    Hunt RH; Cederberg C; Dent J; Halter F; Howden C; Marks IN; Rune S; Walt RP
    Dig Dis Sci; 1995 Feb; 40(2 Suppl):24S-49S. PubMed ID: 7859582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endosonographic evaluation of the quality of ulcer healing induced by proton pump inhibitors.
    Tsukamoto Y; Goto H; Hase S; Niwa Y; Arisawa T; Hayakawa T; Yoshikane H
    J Clin Gastroenterol; 1995; 20 Suppl 2():S40-3. PubMed ID: 7594337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.